Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...

MIT engineers have successfully used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently. Using artificial intelligence, MIT researchers have come up with a ...

A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers by unleashing a potent interferon-driven immune surge that transforms resistant tumors ...

New research from the University of Pittsburgh could help scientists develop the next generation of mRNA vaccines to be more effective and less expensive to produce. A study published this week in NPJ ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Bayer has filed lawsuits in U.S. federal courts seeking a share of the revenue generated from COVID-19 vaccines sold by ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

(TNND) — Health Secretary Robert F. Kennedy Jr.'s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a deeply ...

CAMBRIDGE, MA -- Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies.